Economic Cost of Functional Neurologic Disord...

Dr. Greg Cooper and Dr. David G. Coughlin discuss the role of αSyn-SAAs in diagnosing DBL and their relationship with Alzheimer's disease biomarkers. Show citation: Coughlin DG, Jain L, Khrestian M, et al. CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers ...  Afficher plus

In part one of this two-part series, Dr. Tesha Monteith and Dr. Andrew Hershey summarize findings from the SPACE trial evaluating fremanezumab in adolescents and children with migraine. Show citation: Hershey AD, Szperka CL, Barbanti P, et al. Fremanezumab in Children and Adolesc ...  Afficher plus

The August 2023 replay of past episodes showcases four interviews on functional neurologic disorders with Prof. Jon Stone. The episode begins with an interview by Prof. Jon Stone and Dr. Tamara Pringsheim with Wall Street Journal columnist Julie Jargon about the <a href= "http ...

Dr. Derek Stitt talks with Dr. Karin Diserens about subtle signs and motor behavior to unveil awareness in unresponsive brain-impaired individuals.

Read the related article in <a href= "https://n.neurology.org/content/early/2023/02/28/WNL.0000000000207067" target="_blan ...

Dr. Neha Dangayach talks with Drs. Susanne Muehlschlegel and Adeline Goss about characterizing the prognostic language clinicians use in critical neurologic illness.

Read the related article in <a href= "https://n.neurology.org/content/early/2023/06/08/WNL.0000000000207 ...

The December 2023 replay wraps up the year with four previously posted episodes on neurocritical care. The episode begins with an interview with Dr. Karin Diserens on subtle c ...